A three-dimensional quantitative structure-activity relationship (3D-QSAR) study was performed on 1,3,5-triazine derivatives which were based on Ala16Val + Ser108Thr mutant DHFR inhibitors of Plasmodium falciparum clone (FCR-3). Comparative Molecular Field Analysis (CoMFA) was carried out for designing novel PfDHFR enzyme inhibitors. It is shown that the steric and electrostatic properties by CoMFA contours can be related to the PfDHFR inhibitory activity. Glide-XP of Schro¨dinger was used for docking of PfDHFR inhibitors into the putative binding sites of the PfDHFR.
Introduction
Malaria is one of the most widespread diseases in the world. According to WHO estimates 40% of the world's populations presently live under malarial threat. Around 300 and 500 million cases of malaria occur annually, leading to 1-3 million deaths. 1 Its control is globally a high priority task. Although effective antimalarial agents have been known for a long time, the alarming spread of drug resistant strains of Plasmodium falciparum, which is the most lethal parasite species, undergoes the urgency and continuous need for the discovery of new therapeutics. A major initiative in this direction is to find enzyme targets that are critical to the disease process or essential for the survival of the parasite. Identification and design of novel chemical entities specifically affecting these targets could lead to better drugs for the treatment of malaria. 2 The widespread occurrence of malaria could be attributed to the development of resistance of the parasite to the available antimalarial drugs such as chloroquine, cycloguanil and pyrimethamine. These drugs have been used clinically in the treatment of malaria, especially to P. falciparum malaria for longer period of time. But due to the emergence of drug-resistant parasite in many countries, there is need of new and effective drugs for treatment of malaria. [3] [4] [5] [6] [7] [8] The dihydrofolate reductase (DHFR) domain of a bi-functional enzyme which is known as dihydrofolate reductase-thymidylate synthase (DHFR-TS) is one of the wellestablished drug targets in P. falciparum. It catalyzes NADPH-dependent reduction of 7,8-dihydrofolate (DHF) to 5,6,7,8-teterahydrofolate (THF) that plays a crucial role in many biochemical processes such as folate metabolism and DNA synthesis. Thus, inhibition of DHFR causes interruption of DNA formation which ultimately results in death of the parasitic cells. This observation has been exploited to design antimalarial agents that inhibit the normal function of PfDHFR enzyme. [9] [10] [11] [12] It is a specific target for type-2 anti-folates such as pyrimethamine and cycloguanil. 13 These antimalarial drugs selectively inhibit PfDHFR enzyme without affecting the corresponding enzyme in humans. However, due to point mutations at amino acid residues 16, 51, 59, 108 and 164 in the active site of PfDHFR enzyme, the therapeutic values of cycloguanil and pyrimethamine have dramatically declined in many parts of the world. 14, 15 Such mutations decrease the optimal binding interactions of the drugs and amino acid residues in the active site of PfDHFR enzyme which result in reduction of efficacy. 16 Computer-aided drug design approaches such as pharmacophore mapping, docking, homology modeling and quantitative structure-activity relationships (QSAR) models [17] [18] [19] [20] are some of the approaches which have been employed in understanding parasitic drug resistance, and also in designing antimalarial drug candidates for inhibition of drug-resistant P. falciparum parasite.
Two of the most widely used 3D-QSAR approaches are based on Comparative Molecular Field Analysis (CoMFA) 21 and Comparative Molecular Similarity Index Analysis (CoM-SIA). 22 In CoMFA model, the steric and electrostatic fields are computed based on 3D-structures of ligands in the training set. Partial Least Square (PLS) is then used to derive an equation that correlates the biological activity with the different probes at various lattice points. Different color-coded contour maps surrounding the ligands give insights about favorable and unfavorable ligand-receptor interactions, and also used as guides for designing novel leads. Molecular docking study was carried out to know the possible interaction between DHFR and title compounds.
Results and discussion

Molecular alignment and model generation
The compounds selected for the 3D-QSAR analysis and their estimated biological activities are listed in Table 1 . The 28 compounds were used in the 3D-QSAR analysis. Among the data set used, only 20 molecules were included in the training set and the remaining 08 molecules were used as test set. The choice of compounds as training and test set was performed randomly. The statistic results of CoMFA models were constructed by the minimum energy conformer-based alignment.
Statistical analyses
The CoMFA model with the highest external predictive ability (r 2 pred = 0.740) was selected as the best model. The training set compounds used to generate this model, and the test set compounds are given in Table 1 . The cross-validation coefficient, r 2 cv , and the non-cross validate coefficient, r 2 ncv , of this model were found to be 0.656 and 0.996, respectively, for optimum number of components (ONC) 6. The standard error of estimation (SEE) of this model was 0.033. The summary of statistics of the best CoMFA model is given in Table 2 . The relative contributions of steric and electrostatic fields 76.7% and 23.3%, respectively, indicate that steric interactions are the major contributors for the variation of biological activities of triazine derivatives used in the study.
The schematic representation showing the relative positions of Val16, Thr108 and Asp54 in the active site of Ala16Val + Ser108Thr mutant P. falciparum parasite is given in Fig. 1 whereas the conformation of pyrimethamine bound in the active site of X-ray crystallographic structure of double mutant (S108N + C59R) PfDHFR (Fig. 2 ). As shown in Fig. 2 , the para-chloro phenyl ring of pyrimethamine was displaced from a plane which was perpendicular to the plane of the 2,4-diaminopyrimidine ring. Similar displacement also occurs in the p-chloro phenyl ring of cycloguanil which results in loss of its binding interactions and affinity in the active site of Ala16Val + -Ser108Thr mutant enzyme as compared to that of the wild type.
As indicated in Table 2 , the predictive correlation coefficient (r 2 pred = 0.740) was reasonable to suggest that our model is a satisfactory model with good predictive ability. A high r 2 value (0.999) of bootstrapping which was carried out at 100 runs also supports the statistical validity of the model. 23, 24 The summary of statistics of the CoMFA studies is given in Table 2 .
The comparison between the experimental and predicted activities of the training set and test set compounds ( Table 3) indicated that the CoMFA models show good predictive abilities as demonstrated by the small residual values of both sets of compounds. Fig. 3 shows the graph of predicted vs. experimental activities of the training and test set compounds. The linearity of the graphs also indicates that both the CoMFA ( Fig. 3(A) ) models are predictive enough to be used as guides in designing new molecules.
Contour map analyses
Having obtained a valid CoMFA model, it is possible to identify regions of space around the molecules where changes with altering substitution would lead to an increase or a decrease in biological activity. This has been achieved by using a CoMFA contour map for the model, as shown in Fig. 4 (a) (steric contributions) and in Fig. 4 (b) (electrostatic contributions).
Visual inspection of 3D contour maps generated by CoMFA
The CoMFA steric and electrostatic maps of triazine derivatives used in the study are depicted in Fig. 4 along with the most active compound (16.10) displayed in the background. In these contour maps, the green contours show the regions where sterically bulkier groups are associated with increase in biological activity. On the other hand, yellow contours indicate the regions where such bulkier groups lower biological activities of ligands. 25 For the selected best CoMFA model, green contours were observed near 30-substituent of 5-aryl ring and at about three C-C bonds away from C6 atom of the 1,3,5-triazine ring ( Fig. 4(a) ). The green regions show that increasing steric bulk at these positions results in increased bioactivities of triazine-derivatives. This is consistent with the fact On the other hand, compounds which belong to no sterically bulky substituents fall in the above mentioned green regions. These compounds generally exhibit low activities (pIC 50 < 4.8). Even though they have dimethyl and dimethylamine substituents at C6-position of the triazine ring, could be attributed to the fact that the bulky groups do not fall into the green region. To fall into this region, the length of the bulky group should be about three C-C bonds away from the 1,3,5-triazine ring (or C6 atom) and also another group should be located at 19-position of the 5-aryl ring of triazine derivatives ( Fig. 4(a) ).
The CoMFA electrostatic interaction contour maps ( Fig. 4(b) ) are represented by red and blue regions. The red contours represent regions where electron-rich (electronegative) groups result in enhanced bioactivity whereas blue contours correspond to regions where increased positive charge (or decreased negative charge) would result in an enhanced biological activity. Three small red contours near 30-Cl substituent, and other two small red contours on C6-substituent at about C-C length distance from C6 atom were observed ( Fig. 4(b) ). Comparison of the activities of 16.10 vs. 16.1, 16.28 vs. 16 .23 demonstrated that an electronegative Cl substituent at the 19-position could contribute to the observed high activities of these compounds. Hence, higher activities of 16.10, 16.19 and 16.28 could be attributed to the presence of 19-Cl substituent that falls into the red region.
In this study no compound was found to possess an electron-deficient substituent near the blue regions. The analysis of the CoMFA contour maps also indicated that the most active compounds have bulky and electronegative substituents or at least one of them properly oriented, respectively, at the sterically and electrostatically favorable regions. Occurrence of the green and red contours together suggests the need of both sterically bulky and electron rich substituents in order to increase inhibitory activities of triazine analogs.
Docking analysis
A docking study could offer more insight into understanding the protein-inhibitor interactions and the structural features of active site of protein. Beginning of the docking, it is necessary to validate the docking reliability. The ligand pyrimethamine of the crystal structure of PfDHFR complex as a temple was adopted to perform the validation. 17, 26 The ligand pyrimethamine was flexibly re-docked to the binding site of PfDHFR (PDB ID 1J3J) and the docking conformation corresponding to the lowest energy score was selected as the most probable binding conformation. As a result, the re-docked pyrimethamine and crystal structure pyrimethamine of 1J3J complex are almost at the same position in the active site and the RMSD for all atoms of the two conformers is 0.72 Å , suggesting a high docking reliability of Glide XP. Therefore, the Glide docking protocol and the used parameters could be extended to search the binding conformations to PfDHFR for other inhibitors.
The active site contains the highly conserved residues Asp54, Ala16, Ser120, Ser122, Phe123, Asn124, Phe224, Gly225, Leu119, Phe258, Ile310, Val311, Leu314, Phe315, Gly165, Phe319, Ser380, Ile386, Arg122, consistent with several homology modeling studies. [27] [28] [29] Using Glide docking, all compounds selected from CoMFA study were docked into the putative binding sites of PfDHFR enzyme. The binding score (Gscore) and Glide XP terms of all the compounds are depicted in Table 4 . It should be noticed that the G-Scores of the most compounds are in agreement with their activities.
The outcome of docking studies confirmed that the results can be used for the development of pharmacophoric features based on Glide XP energetic terms. Fig. 5(a) and (b) show the detailed binding mode between the active sites of PfDHFR enzyme and the most active compound 16.10 and the less active compound 16.1. Hydrogenbonds were also labeled to help understand the interactions of the complexes. Analyses of hydrogen-bond interactions confirmed that Ala16 and Gly165 play the relatively important roles in binding potency ( Fig. 5(a) ). The side chain of Ala16 and the backbone of Gly165 are inclined to form the hydrogen-bonds with the hydrogen atoms of amino group at 2-position of compound 16.10. The distances of the hydrogen-bonds between compound 16.10 and amino acid residues of Ala16 and Gly 165 were 2.210 and 2.423 Å , respectively. The angles of the two hydrogen-bonds were 168.60°and 150.24°, respectively. Similarly, the side chain of Asp54 formed a hydrogenbond with the hydrogen atom of amino group of compound 16.1, the distance and angle of the hydrogen-bond were 2.835 Å and 166.20°, respectively. However, we have not observed the hydrogen-bond between compound 16.1 and the backbone of Ala16 and Gly165 ( Fig. 5(b) ).
Materials and methods
Data set
A data set of 28 triazine derivatives was used for the 3D-QSAR study. 30 The compounds were evaluated for their in vitro anti-plasmodial activities of cycloguanil-resistant P. falciparum clone harboring Ala16Val + Ser108Thr mutant PfDHFR enzyme. The reported growth inhibition constant (IC 50 ) values were converted into corresponding pIC 50 using the formula-pIC 50 ¼ À log IC 50 pIC 50 values were used for generation of the CoMFA model. The reported IC 50 values are given in the original literatures. 30 The selection of test and trainee sets was performed randomly. The training set contains 20 and test set contains 08 compounds.
Molecular modeling
All molecular modeling studies were carried out on SYBYL-X 1.3 (SYBYL-X 1.3, Molecular Modeling Software, Tripose Inc., 1699). 31 Since no bound ligand or crystal structure of Ala16Val + Ser108Thr mutant PfDHFR enzyme was available, the lowest energy conformer of the most active compound (16.10) was used as a template for proposition of the bioactive conformation. This is a common approach in ligand based 3D-QSAR studies in the absence of 3D-structural information of the receptor or enzyme. [32] [33] [34] A preliminary minimization was performed on 16.10 to remove close atom or bad van der Waals contacts by using 1000 cycle minimization with standard Tripos force field. A 0.005 kcal/mol energy gradient convergence criterion using Powell's method was also used as a final step of energy minimization. To obtain the lowest energy conformer, 16.10 was then subjected to simulated annealing to heat the molecule at 700 K for 1000 fs followed by annealing the molecule to 200 K for 1000 fs. 25, 35 The resulting conformer with the lowest potential energy was saved and subsequently used as a template. All the remaining molecules were constructed based on this template, and subjected to 1000 cycle minimization with the standard Tripos force field and 0.005 kcal/mol Å energy gradient convergence criterion using Powell's method. All the molecules were assigned with Gasteiger-Huckle charges. 36 Figure 5 Model of compound 16.10 (A) and 16.1 (B) docked into the binding site of PfDHFR. Important residues are shown as sticks.
CoMFA model generation
A Comparative Molecular Field Analysis (CoMFA) was carried out to evaluate steric and electrostatic fields using the QSAR module, and was scaled using the CoMFA standard in SYBYL-X 1.3. All the analyses were performed by placing aligned training set molecules in a 3D grid with a spacing of 2.0 Å . The van der Waals potential and Coulombic terms which represent steric and electrostatic fields, respectively, were calculated using the standard Tripos force fields. A sp 3 hybridized carbon was used as a probe atom to generate the steric (Lennard-Jones potential) field and a charge of +1.0 to generate the electrostatic (Coulomb potential) field. The steric and electrostatic contributions were set at a default cutoff energy value of 30 kcal/mol. Several CoMFA models were developed by permutation of molecules between training and test sets.
Partial Least Square (PLS) analysis
PLS method was used to correlate CoMFA fields with biological activities of compounds. In this study the cross-validation (r 2 cv ) was carried out using leave-one-out (LOO) method which removes one compound from the data set, and its properties predicted from the model developed using the rest of compounds. In order to increase the speed of the analyses and to improve noise-to-signal ratio, all the cross-validations were performed using a column filter value (d) of 2.0 kcal/mol by omitting those lattice points whose energy variation is below this threshold value. After obtaining an optimum number of components in the cross-validation analysis step, a final noncross validated analysis was performed using the optimal number of components obtained from LOO cross-validation step. To further assess the robustness and the statistical validity of the obtained models, bootstrapping analysis for 100 runs was performed. Finally, the model quality was evaluated in terms of the LOO cross-validated correlation coefficient q 2 , the non cross-validation correlation coefficient r 2 , the predictive correlation coefficient r 2 pred , the standard error of estimate S value, and the F-statistic for analysis for F value.
Predictive ability of CoMFA models
To assess the predictive abilities of the CoMFA model derived by the training set, biological activities of an external test set composed of 08 compounds were predicted. The predictive ability of the model is expressed by the predictive correlation coefficient r 2 pred , calculated by the equation as shown below-
where SD is the sum of the squared deviations between the biological activities of the test set and mean activities of the training set compounds; PRESS is the sum of the squared deviations between the actual and predicted activities of the test compounds. 21 
Molecular docking studies
Molecular docking studies were performed in Maestro 9.3 using Glide v5.8 (Schro¨dinger, LLC, New York, NY, 2010). All compounds were built using Maestro build panel and optimized to lower energy conformers using Ligprep v2.5 which uses OPLS_2005 force field. Epik v2.3 was used to generate ionized state of all compounds at target pH 7.0 ± 2.0. The coordinates for PfDHFR enzyme (PDB ID 1J3J) were taken from RCSB Protein Data Bank and prepared for docking using 'protein preparation wizard' in Maestro v9.3. Water molecules in the structures were removed and termini were capped by adding ACE and NMA residue. The bond orders and formal charges were added for hetero groups and hydrogens were added to all atoms in the structure. Side chains that are not close to the binding cavity and do not participate in salt bridges were neutralized. After preparation, the structure was refined to optimize the hydrogen bond network using OPLS_2005 force field. This helps in reorientation of side chain hydroxyl group. The minimization was terminated when the energy converged or the RMSD reached a maximum cutoff of 0.30 Å . Grids were then defined around refined structure by centering on ligand using default box size. The extra precision (XP) docking mode for all compounds was performed on generated grid of protein structure. 37 The final evaluation of ligand-protein binding was done with Glide score (docking score).GScore = a · vdW + b · Coul + Lipo + 
Conclusions
The main objective of this study was to develop statistically robust CoMFA models with good correlation and predictive powers using anti-plasmodial activity data of triazine derivatives. The CoMFA model was found to give better result as demonstrated by its statistical indices (r 2 cv = 0.656, r 2 ncv = 0.996, r 2 bs = 0.999 and r 2 pred = 0.740). The constructed 3D-QSAR models and structure-activity relationship (SAR) analyses of the compounds used in the study suggested that an electronegative and bulky substituent at 30-position and one bulky substituent at C6-position of triazine analogs are required to design novel inhibitors of Ala16 Val + Ser108Thr mutant PfDHFR enzyme. The docking studies provide useful information for understanding the hydrogenbonding interactions between the inhibitors and the active site residues of the Ala16 Val + Ser108Thr mutant PfDHFR enzyme. The CoMFA model and the docking studies may afford the guidance for designing new potential DHFR inhibitors.
Conflict of interest
The authors confirm that this article content has no conflicts of interest.
